149 related articles for article (PubMed ID: 15808545)
1. Antigen-specific T-lymphocyte responses in acute and chronic syngeneic graft-versus-host disease.
Hess AD; Thoburn CJ; Miura Y; Bright EC
Transplant Proc; 2005; 37(1):53-6. PubMed ID: 15808545
[TBL] [Abstract][Full Text] [Related]
2. Functional divergence of antigen-specific T-lymphocyte responses in syngeneic graft-versus-host disease.
Thoburn CJ; Miura Y; Bright EC; Hess AD
Biol Blood Marrow Transplant; 2004 Sep; 10(9):591-603. PubMed ID: 15319771
[TBL] [Abstract][Full Text] [Related]
3. Unexpected T-cell diversity in syngeneic graft-versus-host disease revealed by interaction with peptide-loaded soluble MHC class II molecules.
Hess AD; Thoburn CJ; Chen W; Bright AE
Transplantation; 2003 Apr; 75(8):1361-7. PubMed ID: 12717231
[TBL] [Abstract][Full Text] [Related]
4. Characterization of the autoreactive T cell repertoire in cyclosporin-induced syngeneic graft-versus-host disease. A highly conserved repertoire mediates autoaggression.
Fischer AC; Ruvolo PP; Burt R; Horwitz LR; Bright EC; Hess JM; Beschorner WE; Hess AD
J Immunol; 1995 Apr; 154(8):3713-25. PubMed ID: 7706714
[TBL] [Abstract][Full Text] [Related]
5. Characterization of the pathogenic autoreactive T cells in cyclosporine-induced syngeneic graft-versus-host disease.
Chen W; Thoburn C; Hess AD
J Immunol; 1998 Dec; 161(12):7040-6. PubMed ID: 9862741
[TBL] [Abstract][Full Text] [Related]
6. Complexity of effector mechanisms in cyclosporine-induced syngeneic graft-versus-host disease.
Hess AD; Thoburn CJ; Chen W; Horwitz LR
Biol Blood Marrow Transplant; 2000; 6(1):13-24. PubMed ID: 10707995
[TBL] [Abstract][Full Text] [Related]
7. Characterization of peripheral autoregulatory mechanisms that prevent development of cyclosporin-induced syngeneic graft-versus-host disease.
Hess AD; Fischer AC; Horwitz L; Bright EC; Laulis MK
J Immunol; 1994 Jul; 153(1):400-11. PubMed ID: 8207251
[TBL] [Abstract][Full Text] [Related]
8. Effector mechanisms in cyclosporine A-induced syngeneic graft-versus-host disease. Role of CD4+ and CD8+ T lymphocyte subsets.
Hess AD; Fischer AC; Beschorner WE
J Immunol; 1990 Jul; 145(2):526-33. PubMed ID: 1973185
[TBL] [Abstract][Full Text] [Related]
9. Autoimmune-mediated vasculopathy.
Chen W; Thoburn CJ; Miura Y; Sommer M; Hruban R; Qian Z; Baldwin W; Hess AD
Clin Immunol; 2001 Jul; 100(1):57-70. PubMed ID: 11414746
[TBL] [Abstract][Full Text] [Related]
10. Th1 cytokines and NK cells participate in the development of murine syngeneic graft-versus-host disease.
Flanagan DL; Jennings CD; Bryson JS
J Immunol; 1999 Aug; 163(3):1170-7. PubMed ID: 10415011
[TBL] [Abstract][Full Text] [Related]
11. Immune tolerance to self-major histocompatibility complex class II antigens after bone marrow transplantation: role of regulatory T cells.
Hess AD; Thoburn CJ
Biol Blood Marrow Transplant; 2006 May; 12(5):518-29. PubMed ID: 16635787
[TBL] [Abstract][Full Text] [Related]
12. Host resistance to cyclosporine induced syngeneic graft-versus-host disease. Requirement for two distinct lymphocyte subsets.
Fischer AC; Laulis MK; Horwitz L; Beschorner WE; Hess A
J Immunol; 1989 Aug; 143(3):827-32. PubMed ID: 2526175
[TBL] [Abstract][Full Text] [Related]
13. Murine syngeneic graft-versus-host disease is responsive to broad-spectrum antibiotic therapy.
Brandon JA; Jennings CD; Kaplan AM; Bryson JS
J Immunol; 2011 Mar; 186(6):3726-34. PubMed ID: 21296982
[TBL] [Abstract][Full Text] [Related]
14. Autologous graft-vs-host disease: mechanisms and potential therapeutic effect.
Hess AD; Jones RC; Santos GW
Bone Marrow Transplant; 1993; 12 Suppl 3():S65-9. PubMed ID: 8124261
[TBL] [Abstract][Full Text] [Related]
15. Functionally divergent T lymphocyte responses induced by modification of a self-peptide from a tumor-associated antigen.
Hess AD; Thoburn CJ; Miura Y; Bright EC
Clin Immunol; 2005 Mar; 114(3):307-19. PubMed ID: 15721842
[TBL] [Abstract][Full Text] [Related]
16. Analysis of V beta T-cell receptor repertoire of effector mechanisms in acute and chronic graft versus host disease.
Fischer AC; Ruvolo PP; Horwitz LR; Hess AD
Transplant Proc; 1995 Feb; 27(1):1366-9. PubMed ID: 7878914
[No Abstract] [Full Text] [Related]
17. Graft-versus-host disease after autologous bone marrow transplantation: a realistic expectation?
Niederwieser D; Eibl B; Nachbaur D
Wien Med Wochenschr; 1995; 145(2-3):25-7. PubMed ID: 7762248
[TBL] [Abstract][Full Text] [Related]
18. Modulation of graft-versus-host disease: role of regulatory T lymphocytes.
Hess AD
Biol Blood Marrow Transplant; 2006 Jan; 12(1 Suppl 2):13-21. PubMed ID: 16399597
[TBL] [Abstract][Full Text] [Related]
19. Promiscuous recognition of major histocompatibility complex class II determinants in cyclosporine-induced syngeneic graft-versus-host disease: specificity of cytolytic effector T cells.
Hess AD; Thoburn C; Horwitz L
Transplantation; 1998 Mar; 65(6):785-92. PubMed ID: 9539089
[TBL] [Abstract][Full Text] [Related]
20. The nephritogenic T cell response in murine chronic graft-versus-host disease.
Meyers CM; Tomaszewski JE; Glass JD; Chen CW
J Immunol; 1998 Nov; 161(10):5321-30. PubMed ID: 9820505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
